This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Early Registration Savings Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event from March 14-17, 2022
Attend In-Person or 100% Digitally!San Diego Convention Center, San Diego, California

Benjamin Haley, PhD
Senior Principal Scientist at Genentech, Inc


During his graduate studies at UMass Medical School, Ben unravelled several biochemical mechanisms that characterize the RNAi pathway. After receiving his PhD, he went to Michael Levine’s lab at UC Berkeley as an American Cancer Society Postdoctoral Fellow. There, he developed an enhanced Drosophila RNAi system for in vivo applications, further refined the in vivo specificity of RNAi, and identified novel aspects of small RNA biogenesis and mRNA structure/expression using a host of model organisms. Following his postdoc, Ben joined Genentech, Inc. where he currently serves as a point person for applied functional genetics. His lab is focused on developing technologies to better model human disease and therapeutic intervention using cell-based experiments.

Agenda Sessions

  • End-to-end platform optimization for gain-, loss-, and modification-of-function genetic engineering